Abstract:Background: Cystatin C (CysC) has been proposed as a filtration marker for the early detection of acute kidney injury (AKI); however, a wide range of its predictive accuracy has been reported.Study Design: Meta-analysis of diagnostic test studies.Setting & Population: Various clinical settings of AKI, including patients after cardiac surgery, pediatric patients, and critically ill patients.Selection Criteria: Computerized search of PubMed, Current Contents, CINAHL, and EMBASE from inception until November 15, 2010, was performed to identify potentially relevant articles. Inclusion criteria were studies investigating the diagnostic accuracy of CysC level to predict AKI. There were no language restrictions in the search.Index Tests: Increasing or increased serum CysC level or urinary CysC excretion.Reference Tests: The outcome was the development of AKI, primarily based on serum creatinine level (definition varied across studies).Results: We analyzed data from 19 studies and 11 countries involving 3,336 patients. Of these studies, 13 could be included in the meta-analysis. Across all settings, the diagnostic OR for serum CysC level to predict AKI was 23.5 (95% CI, 14.2-38.9), with sensitivity and specificity of 0.84 and 0.82, respectively. The area under the receiver operating characteristic curve (AUROC) of serum CysC level to predict AKI was 0.96 (95% CI, 0.95-0.97). Subgroup analysis showed that serum CysC was of diagnostic value when measured early (within 24 hours after renal insult or intensive care unit admission). For the diagnostic value of urinary CysC excretion, the diagnostic OR was 2.60 (95% CI, 2.01-3.35), with sensitivity and specificity of 0.52 and 0.70, respectively. The AUROC of urinary CysC excretion to predict AKI was 0.64 (95% CI, 0.62-0.66).Limitations: Variation in criteria for definitions of index and reference tests, absence of measured glomerular filtration rate in most studies.Conclusion: Serum CysC appears to be a good biomarker in the prediction of AKI, whereas urinary CysC excretion has only moderate diagnostic value. Am J Kidney Dis. 58(3): 356-365. (C) 2011 by the National Kidney Foundation, Inc.

Research of serum cystatin-C as a maker for the evaluation of renal function in patients with urethral stricture

The Value of Cystatin C in renal Dysfunction Related to Percutaneous Coronary Intervention

The Impact of Serum Cystatin C on Short Term Prognosis in Petients With Ischemic Heart Failure

Cystatin C in Evaluating Renal Function in Ureteral Calculi Hydronephrosis in Adults.

Detecting Serous Levels of Cystatin C and Exploring its Role in the Evaluation of Glomerular Filtration Function

Elevated serum cystatin C at continuous renal replacement therapy initiation predicts lack of renal recovery.

The Preoperative Serum Cystatin-C As an Independent Prognostic Factor for Survival in Upper Tract Urothelial Carcinoma

Cystatin C in Prediction of Acute Kidney Injury: A Systemic Review and Meta-analysis

A study on the early diagnostic values of the serum cystatin C in the renal function impairment of the elderly patients with the primary hypertension

Serum Cystatin C is Associated with Renal Function Recovery in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

Serum Cystatin C Level is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors

The investigation of relationship between TGF-β1 in the urine and chemokine receptor CXCR3 in the urethral scar ifbroblast:A preliminary study

Analysis of the Changes of TGF-β1 in the Urine of Patients with Urethral Strictures

Pretreatment Serum Cystatin C Levels Predict Renal Function, but Not Tumor Characteristics, in Patients with Prostate Neoplasia

Increased Expression of Connective Tissue Growth Factor in Patients with Urethral Stricture

The Measurement of Serum Cystatin C for Renal Function of Patients with Malignant Tumors

Implication of serum Cystatin C in early evaluation of contrast induced renal injury

Serum cystatin C levels in patients with acute myocardial infarction following coronary artery drug stent implantation:Predictive value of cardiovascular events and target vessel lesion

Study on the Clinical Significance of Serum Cystatin C in Different Stage of Renal Impairment in Type 2 Diabetic Patients

The Clinical Significance and Changes of CysC, Hey and PTH Levels of Patients with Chronic Renal Failure before and after Treatment

Clinical significance of serum cystatin C in early evaluation of renal impairment caused by chemotherapy in elderly patients